APLM Apollomics highlights oncology pipeline progress and upcoming clinical trial milestones in its latest quarterly earnings report COEP Coeptis posts narrower Q3 2024 loss than analyst estimates shares rise slightly on upbeat investor sentiment BSAAR BESTSPAC Rts does not publish quarterly earnings data as it assesses viable business combination opportunities